Caris Life Sciences (CAI) total debt

Total debt · fiscal 2025
$427.69M

Caris Life Sciences (CAI) carried total debt of $427.69M at the end of fiscal 2025 (December 31, 2025). That is 0.8% higher than the $424.26M of fiscal 2024. Figures as of 18 Nov 2026, 07:38 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
$427.69M
Change on fiscal 2024
+0.8%
Highest on record
$427.69Mfiscal 2025
Lowest on record
$217.11Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Caris Life Sciences total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $427.69M in fiscal 2025 and the lowest $217.11M in fiscal 2023.

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Caris Life Sciences total debt, year by year

Caris Life Sciences (CAI) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$427.69M 0.8% up0.7×
2024$424.26M 95.4% up—
2023$217.11M 19.8% down—
2022$270.87M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Caris Life Sciences and comparable companies
CompanyTotal debtFiscal year
Cytokinetics CYTK$1.28B2025
ABIVAX ABVX€1.86M2025
Bausch + Lomb BLCO$5.08B2025
Amneal Pharmaceuticals AMRX$2.69B2025
Caris Life Sciences CAI$427.69M2025
Immunovant IMVT$72.00K2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CAI

Caris Life Sciences, figure by figure

Caris Life Sciences (CAI) overview: price, valuation and scorecardAll health care companies by market value

Caris Life Sciences total debt: questions and answers

How much debt does Caris Life Sciences have?

Caris Life Sciences (CAI) carried total debt of $427.69M at the end of fiscal 2025 (December 31, 2025). That is 0.8% higher than the $424.26M of fiscal 2024.

What are the highest and lowest total debt figures on record for Caris Life Sciences?

Across the 4 fiscal years on record (2022–2025), the highest was $427.69M in fiscal 2025 and the lowest $217.11M in fiscal 2023.

How does Caris Life Sciences's debt compare with its equity?

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

How is Caris Life Sciences's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Caris Life Sciences (CAI) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/CAI/total-debt

Underlying data: Yahoo Finance.